Summary
Bhubaneswar-based biotech company Exsure is developing a novel drug delivery system using exosomes to make chemotherapy less toxic and target cancer stem cells. The company, founded in 2021, recently raised Rs 3 crore in a seed round led by Unicorn India Ventures to advance its preclinical studies and expand sales of its research products.